Dr. Sridevi Challapalli, MD

Dr. Challapalli practices at Reno Vein Surgery Center in Reno, Nevada.

Dr. Challapalli's NPI, 1063404721, was assigned on August 18, 2005. Dr. Challapalli graduated from UT Southwestern Medical Center in 1992. Dr. Challapalli holds Nevada license 8810.

Dr. Challapalli's primary practice is Reno Vein Surgery Center, at 4790 Caughlin Pkwy, Reno, NV 89519 in Washoe County. The practice phone is (775) 329-3100.

Dr. Challapalli's primary practice is Reno Vein Surgery Center in Reno, Nevada. Dr. Challapalli is also affiliated with Renown Regional Medical Center. The medical group on file is Challapalli Cardiology. Dmand AI also links Dr. Challapalli to 4 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Challapalli practices, 6 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Challapalli's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Challapalli is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Challapalli's licenses on file in 4 states: Nevada, California, Georgia and Illinois.

Dmand AI lists aneurysm, angioplasty, aortic atherosclerois, atrial fibrillation and flutter, cardiac arrhythmia, cardiac catheterization, cardiomyopathy and cerebrovascular disease among the conditions Dr. Challapalli treats.

CMS data shows 8,072 Medicare services from Dr. Challapalli across 26 procedure codes in 2024, for 1,027 Medicare patients. Medicare paid $1,530,278 for them. Every service was in an office.

CMS counts 1,027 Medicare patients who saw Dr. Challapalli in 2024. The largest group is 65 to 74, with 473 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 3% are also on Medicaid. Their average risk score is 1.16, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Challapalli's median patient age at 70, with 49% women.

In 2024, Dr. Challapalli wrote 5,091 Medicare Part D claims for 819 patients. 85% of them were for generic drugs. CMS names the drug for 4,866 of them, across 48 drugs with 11 or more claims each, at $906,203 in total drug cost. In 2023, CMS named 5,541 claims across 56 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Dr. Challapalli for performance year 2024, reported individually. Dr. Challapalli accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Challapalli as offering telehealth.

Dmand AI links 4 papers to Dr. Challapalli. The most frequent topics are Electrocardiography. Dr. Challapalli has published most often in Circulation. Dr. Challapalli's most frequent co-authors are Jeffrey J. Goldberger, MD, Mirza W. Ahmed, MD and Robert O. Bonow, MD.

CMS Open Payments shows 604 general payments to Dr. Challapalli from 41 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 68% of the total. Novartis Pharmaceuticals Corporation paid the most, $5,909.

Dr. Challapalli graduated from UT Southwestern Medical Center in 1992.

Dr. Challapalli is in network with 15 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.